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Abstract
Background: Although many countries experience an increase in mortality during winter, the
magnitude of this increase varies considerably, suggesting that some winter excess may be
avoidable. Conflicting evidence has been presented on the role of gender, region and deprivation.
Little has been published on the magnitude of excess winter mortality (EWM) in New Zealand (NZ)
and other Southern Hemisphere countries.
Methods:  Monthly mortality rates per 100,000 population were calculated from routinely
collected national mortality data for 1980 to 2000. Generalised negative binomial regression
models were used to compare mortality rates between winter (June–September) and the warmer
months (October–May).
Results: From 1980–2000 around 1600 excess winter deaths occurred each year with winter
mortality rates 18% higher than expected from non-winter rates. Patterns of EWM by age group
showed the young and the elderly to be particularly vulnerable. After adjusting for all major
covariates, the winter:non-winter mortality rate ratio from 1996–2000 in females was 9% higher
than in males. Mortality caused by diseases of the circulatory system accounted for 47% of all
excess winter deaths from 1996–2000 with mortality from diseases of the respiratory system
accounting for 31%. There was no evidence to suggest that patterns of EWM differed by ethnicity,
region or local-area based deprivation level. No decline in seasonal mortality was evident over the
two decades.
Conclusion: EWM in NZ is substantial and at the upper end of the range observed internationally.
Interventions to reduce EWM are important, but the surprising lack of variation in EWM by
ethnicity, region and deprivation, provides little guidance for how such mortality can be reduced.
Background
Seasonal fluctuations in mortality have been documented
since 400BC [1]. Although many countries currently expe-
rience an increase in mortality during winter, the magni-
tude of this increase varies considerably, suggesting that
some winter excess may be avoidable. Paradoxically, rela-
tive seasonal variation in mortality appears lowest in
countries with cold winters, such as Russia, Norway and
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Canada and is higher in Britain, Israel and Portugal where
winters are milder [2-5]. In Britain around 40,000 more
deaths occur in the winter months than expected from the
non-winter mortality rates [6].
Infant mortality displays the characteristic winter high
and summer low [7]. Seasonal mortality is greatest in the
elderly but British data indicate it is not confined to this
age group, with one study reporting that the chance of
dying in winter exceeded that in the rest of the year by
more than 10% in the 46–64 years age group [4].
Evidence for a gender difference in winter mortality is
inconsistent [4,6]. Limited research has been conducted
on the association between seasonal variation in mortality
and ethnicity [7]. Although the relationship between
overall mortality and social deprivation is unquestiona-
ble, the extent to which socioeconomic factors impact on
seasonal excess mortality is unclear. In a cross-country
analysis, strong relationships were found between EWM
and relative income poverty, inequality, deprivation and
fuel poverty [8]. In Great Britain from 1986 to 1996, there
was little association between deprivation and EWM for
all cause mortality although lack of central heating was
associated with increased seasonal mortality [9].
Localised climates experienced by different geographical
regions within a country do not consistently lead to differ-
ences in extent of seasonality of mortality by region [4,6].
EWM from 1976–1987 for ten standard regions of Eng-
land and Wales displayed little variation whereas Swedish
mortality data from 1974–1984 indicated a strong
regional association between cold exposure and high cor-
onary mortality [4,10].
Following the recent decline in influenza epidemics,
about half of all excess cold-related mortality can be
attributed to Ischaemic Heart Disease (IHD) and Cere-
brovascular Disease (CVD) mortality. Respiratory disease
(RD) mortality accounts for nearly half of the remaining
excess [11-13]. In a number of countries including the
Netherlands and Germany, a decline in seasonal mortality
has been observed over the last century [14,15].
Research into seasonal mortality in NZ is limited and has
mainly focused on particular causes of mortality. Using
national mortality data in over 35 year olds from 1970–
83, seasonal aspects of coronary heart disease were
reported with peak winter (mid-July) to summer variation
estimated to be 35% [16]. Mortality from 1980–1984
indicated the presence of major seasonal variation by
month in coronary heart disease and CVD mortality for
males, females and both islands of NZ [17].
The objective was to describe the size and distribution of
seasonal mortality in NZ, in particular the patterns of
EWM by age, gender, ethnicity, region and deprivation.




Routinely collected mortality data were obtained from the
New Zealand Health Information Service (NZHIS), Min-
istry of Health, for all deaths registered from 1 January
1980 to 31 December 2001. As mortality data are pro-
vided according to registration date, deaths occurring out-
side of this period were excluded. Due to expected under-
representation of mortality in 2001 due to late registra-
tion, mortality that occurred after 31 January 2001 was
not included.
If an individual's ethnic group was recorded as Maori, eth-
nicity was assumed to be Maori; all remaining individuals
were categorised as Non-Maori. Four Regional Health
Authorities (RHAs) were used for the geographical analy-
sis. The NZDep ordinal scale, which is based on 9 census
variables that reflect aspects of material and social depri-
vation, was used to provide small-area level deprivation
scores [18]. NZDep96, available for all of NZ's 1700 Cen-
sus Area Units (CAUs), assigns a score of 1 to the decile of
census areas with the least deprivation and 10 to CAUs
with the most deprived scores. Cause of death was exam-
ined based on ICD-10 chapter classification.
Population denominators
Population denominators, obtained from Statistics New
Zealand (SNZ), were counts from the 5-yearly censuses
and estimates for the non-census years. Population esti-
mates stratified by age group, gender, ethnicity, DHB and
NZDep for the 1996 and 2001 censuses were also
obtained from SNZ.
Methods of data analysis
Monthly mortality rates per 100,000 were calculated with
all months standardised to 30-days with adjustment for
leap years. In line with research in the Northern Hemi-
sphere, four-month seasons were used with winter in NZ
defined as June to September. [8,19] Absolute EWM refers
to the difference between the four-month winter mortality
and the average mortality in the preceding summer/
autumn (in NZ, February–May) and successive spring/
summer (in NZ, October–January); relative EWM is the
ratio of these. The relative winter:non-winter EWM less
one gives the percentage that the observed winter deaths
is above that which is expected from the non-winter
deaths. This has previously been referred to as the Coeffi-
cient of Seasonal Variation in Mortality (CSVM) and the
Excess Winter Death Index (EWDI). [4,8]BMC Public Health 2007, 7:263 http://www.biomedcentral.com/1471-2458/7/263
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We used regression models for rates in order to obtain
inferences for mortality rate ratios (MRRs) assessing the
extent to which mortality rates in winter differed from
non-winter. As goodness-of-fit tests indicated that a Pois-
son distribution was not adequate for modelling the proc-
ess generating the mortality counts, MRRs were estimated
using a generalised negative binomial regression model.
This model is a version of the negative binomial model in
which the overdispersion parameter can be modelled as a
function of other variables, allowing a much improved fit
to data such as these [20].
The count of mortality events was the outcome variable,
person-years divided into winter and non-winter periods
relative to the number of winter and non-winter days in
each year reflected the population exposed and a binary
winter indicator (0 = non-winter, 1 = winter) was included
as the explanatory variable. Inclusion of age (6 categories;
0–4, 5–14, 15–29, 30–59, 60–79, 80+ years), gender, eth-
nicity (Maori or non-Maori), region (RHA level), NZDep
and the interactions of these with the winter indicator in
the regression model enabled analysis of the extent to
which particular population subgroups had different
EWM rates. Because of inconsistent definitions of ethnic-
ity and changing regional boundaries over time, the full
model including age, gender, ethnicity, region and
NZDep was restricted to mortality events that occurred in
the most recent 5-year period for which data were availa-
ble. Using a four month winter period and restricting to
the winters of 1996–2000, the dataset included all deaths
occurring between 1 February 1996 and 31 January 2001.
Subsets based on cause of death were analysed using the
same regression model.
The percentage of EWM attributable to particular causes of
death was calculated by obtaining the difference between
the winter and non-winter mortality rates per 100,000
person-years for each ICD-10 chapter and dividing by the
total excess which was calculated from the sum of differ-
ences that indicated EWM had occurred.
Stata version 8.2 was used for all statistical analysis [21].
Results
Seasonal mortality; 1980–2000
For the 21-year period from 1 February 1980 to 31 January
2001, there were 565,308 registered deaths. Monthly fre-
quencies indicate strongly that seasonal mortality does
occur in NZ (Figure 1). Mortality was typically highest in
July and lowest in February with on average, 600 more
deaths occurring in July than in February. Annual peaks in
mortality varied considerably in magnitude. In compari-
son with the lowest monthly mortality rate recorded in
January 1994, the 3075 deaths that occurred in August
1980 produced a mortality rate that was almost twice as
large.
Absolute EWM over this period ranged from 818 in 1984
to 2388 in 1996. The absolute EWM rate was highest in
1980 when there were 71 excess winter deaths per
100,000 and lowest in 2000 when 21 excess winter deaths
per 100,000 occurred. Over the 21-year period, an average
of almost 1600 excess winter deaths occurred each year at
a rate of 45 per 100,000.
The estimated winter:non-winter all-cause MRRs for each
year from 1980 to 2000 indicate that relative seasonal
EWM was clearly greater in some years than others (Figure
2). Mortality during winter 1996 was 25.6% (95% confi-
dence interval (CI) 21.1% to 30.4%) higher than
expected, the largest observed over this 21 year period.
The winter of 1984 had the lowest estimated MRR with
Annual variation in estimated winter:non-winter all-cause  mortality rate ratios from 1980 to 2000 Figure 2
Annual variation in estimated winter:non-winter all-cause 
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Monthly variation in crude mortality and monthly (30-day) 
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winter mortality 10.3%, (95% CI 6.3% to 14.4%) higher
than expected. There was no evidence for a secular trend
in EWM over this 21-year period (p = 0.9). Over this 21
year period, mortality was estimated to be 18.4% (95% CI
5.9% to 32.4%) higher during winter than expected.
Detailed analysis of seasonal mortality; 1996–2000
From 1 February 1996 to 31 January 2001 there were
137,583 registered deaths in NZ with gender, age group,
prioritised ethnicity, region and NZDep recorded for
95.7%. Total all-cause mortality during winter occurred at
a rate of 8.0 per 1000 person years over this 5-year period;
14% higher than expected from non-winter rates. Unad-
justed winter:non-winter ratios indicate winter mortality
was higher than expected in those aged sixty years or older
(Table 1).
The exponentiated coefficients of the winter-by-explana-
tory-variable interaction terms from the generalised nega-
tive binomial regression model are ratios of the
winter:non-winter MRRs relative to a baseline category of
the explanatory variable. These estimates can be inter-
preted as "relative risks" of excess winter deaths compared
with the baseline. After adjusting for all other covariates,
estimates of the magnitude of winter:non-winter mortal-
ity suggested higher mortality in under 5-year olds than in
those aged 5–59. Mortality in those aged eighty or over
appeared most affected by winter with an estimated 10%
higher incidence in winter than non-winter relative to that
in the under-fives. After adjusting for all other covariates
in the model it was estimated that females were 9% more
likely to die in winter than males. There was no evidence
to suggest that winter:non-winter MRRs differed by eth-
nicity, NZDep or RHA. A three-way interaction term that
allowed winter:non-winter MRRs to differ by gender
across age groups provided insufficient statistical evidence
(p = 0.6) to warrant inclusion in the final model.
Mortality in the 5–14 age category was relatively rare with
only 550 (0.4%) deaths over the five years. Combination
of this age group with the under-fives age group produced
similar results indicating analysis using 6 age groups was
insensitive to the relatively few deaths in this age group.
Table 1: Rates of all-cause mortality in winter and non-winter months, ratio of rates and relative change in winter:non-winter ratios for 
potential modifying factors; 1996–2000
p-value




Winter:non-winter ratio relative 
to baseline category§ (95% CI)‡
Winter Non-winter
All 8.0 (49232) 6.7 (82427) 1.14 (0.98, 1.33)
Age (years):
0–4 1.7 (772) 1.5 (1407) 1.12 (0.91, 1.38) 1.00
5–14 0.2 (174) 0.2 (376) 0.93 (0.75, 1.17) 0.84 (0.68, 1.03)
15–29 0.9 (1120) 0.9 (2240) 1.01 (0.79, 1.27) 0.91 (0.75, 1.09)
30–59 2.5 (6188) 2.4 (11572) 1.04 (0.86, 1.26) 0.96 (0.84, 1.10)
60–79 25.1 (20123) 21.2 (33915) 1.15 (0.98, 1.35) 1.05 (0.92, 1.20)
80+ 122.8 (20855) 97.2 (32917) 1.23 (1.11, 1.36) 1.10 (0.92, 1.31) p = .09
Gender:
Male 8.3 (24882) 7.1 (42628) 1.10 (0.91, 1.34) 1.00
Female 7.8 (24350) 6.4 (39799) 1.20 (0.99, 1.46) 1.09 (1.01, 1.19) p = .04
Ethnicity†:
Non-Maori 7.7 (44583) 6.4 (74116) 1.19 (1.02, 1.40) 1.00
Maori 13.2 (4649) 11.3 (8311) 1.13 (0.94, 1.34) 1.01 (0.91, 1.10)  p = .92
NZDep96:
1–3 6.9 (11341) 5.7 (18869) 1.11 (0.85, 1.44) 1.00
4–6 7.9 (14693) 6.7 (24689) 1.14 (0.89, 1.46) 0.97 (0.87, 1.08)
7–10 8.8 (23198) 7.4 (38869) 1.16 (0.91, 1.18) 0.97 (0.87, 1.08)  p = .78
RHA:
North 7.1 (15039) 6.0 (25479) 1.23 (0.92, 1.65) 1.00
Midland 8.2 (10040) 7.0 (16925) 1.08 (0.80, 1.45) 0.97 (0.87, 1.10)
Central 8.3 (12478) 6.9 (20498) 1.18 (0.88, 1.58) 1.06 (0.94, 1.19)
South 8.9 (11675) 7.5 (19525) 1.08 (0.80, 1.46) 1.01 (0.89, 1.14)  p = .55
* No of deaths in winter correspond to a 4 month period; non-winter, an 8 month period
‡ Generalised negative binomial regression model; overdispersion a linear combination of age group and 
ethnicity
§ Adjusted for all other covariates including covariate by winter interaction terms
† Mortality rates have been age-standardised to account for different population structures of Maori and Non-
MaoriBMC Public Health 2007, 7:263 http://www.biomedcentral.com/1471-2458/7/263
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Mortality from diseases of the respiratory system was most
dependent on seasonal effects; with a winter mortality rate
that was 83%, (95% CI 71%, 96%) higher than expected
from the non-winter rates (Table 2). Mortality from dis-
eases of the blood and blood-forming organs and certain
disorders involving the immune mechanism, endocrine,
nutritional and metabolic diseases, diseases of the circula-
tory system and diseases of the digestive system were esti-
mated to occur between 20%–26% more often in winter
than in non-winter. Symptoms, signs and abnormal clin-
ical and laboratory findings, not elsewhere classified
caused mortality in winter around 47% more often in
winter than in non-winter. For certain infectious and par-
asitic diseases, the corresponding estimate was 68%. Six
percent of EWM was attributable to mortality from neo-
plasms, 3.6% from diseases of the blood and blood-form-
ing organs and certain disorders involving the immune
mechanism and 3.3% from endocrine, nutritional and
metabolic diseases. Seasonal mortality attributable to
each of the remaining causes was less than 2%.
Mortality caused by diseases of the circulatory system
accounted for 47% of all excess winter deaths over this 5-
year period with mortality from diseases of the respiratory
system accounting for 31%. The mortality rate for diseases
of the respiratory system during winter was 9.4 per 10,000
person years over this 5-year period; 66% higher than
expected from non-winter rates (Table 3). For under-five
year olds, mortality associated with respiratory disease
was estimated to be almost 2.5 times higher in winter than
expected. From the age of 15, increasing age was associ-
ated with increasing winter:non-winter respiratory disease
MRRs with those aged eighty or older 66% more likely to
die in winter than expected. The winter excess of respira-
tory mortality was slightly higher for females than males
(p = 0.08) but there was no evidence to suggest that win-
ter:non-winter mortality differs by age, ethnicity, region or
deprivation.
The mortality rate for diseases of the circulatory system
during winter was 33.7 per 10,000 person years over this
5-year period; 24% higher than expected from non-winter
rates (Table 4). Almost eighty percent of mortality from
diseases of the circulatory system was caused by IHD
(56%) and CVD (23%). The winter:non-winter mortality
ratio for IHD over this five-year period was 1.17 (95% CI
1.13, 1.21) and for CVD it was 1.19 (95% CI 1.13, 1.26).
After adjusting for all other covariates in the regression
Table 2: Rates of death in winter and non-winter months, ratio of rates and relative change in winter:non-winter ratios for all causes of 
death; 1996–2000
Rate per 1000 person years (No of deaths)* Winter:non-winter ratio (95% CI)§
Winter Non-winter
ICD 10 Chapter‡
I Infection 5.4 (332) 3.4 (422) 1.68 (1.38, 2.05)
II Neoplasms 214.9 (13184) 206.7 (25297) 1.03 (0.98, 1.08)
III Blood etc. 18.7 (1150) 14.0 (1719) 1.26 (1.11, 1.43)
IV Endocrine etc. 28.3 (7733) 23.8 (2916) 1.25 (1.12, 1.39)
VI Mental 4.4 (271) 4.9 (602) 0.91 (0.70, 1.18)
VI Nervous 16.6 (1017) 14.0 (1716) 1.11 (0.96, 1.27)
VII Eye 0.0 (0) 0.0 (2)
VIII Ear 0.1 (5) 0.1 (13) 0.75 (0.21, 2.72)
IX Circulatory 350.2 (21482) 287.5 (35189) 1.20 (1.15, 1.24)
X Respiratory 97.9 (6005) 57.4 (7027) 1.83 (1.71, 1.96)
XI Digestive 21.5 (1319) 18.4 (2247) 1.25 (1.11, 1.40)
XII Skin 1.9 (114) 1.5 (184) 1.29 (0.97, 1.71)
XIII Musculoskeletal 6.1 (375) 5.1 (626) 1.14 (0.94, 1.39)
XIV Genitourinary 10.9 (667) 9.5 (1167) 1.11 (0.96, 1.29)
XV Pregnancy 0.1 (4) 0.1 (15) 0.87 (0.25, 3.03)
XVI Perinatal 3.6 (223) 3.6 (436) 0.95 (0.76, 1.19)
XVII Congenital 5.4 (333) 4.9 (605) 1.15 (0.94, 1.41)
XVIII Symptoms 4.2 (256) 3.1 (381) 1.47 (1.20, 1.81)
XIX Injury 45.0 (2760) 47.3 (5789) 0.93 (0.91, 1.08)
* No of deaths in winter correspond to a 4 month period; non-winter, an 8 month period
‡ I: Certain infectious and parasitic diseases; II: Neoplasms; III: Diseases of the blood and blood-forming organs and certain disorders involving the 
immune mechanism; III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism; IV: Endocrine, 
nutritional and metabolic diseases; V: Mental and Behavioural disorders; VI: Diseases of the nervous system; VII: Diseases of the eye and adnexa; VIII: 
Diseases of the ear and mastoid process; IX: Diseases of the circulatory system; X: Diseases of the respiratory system; XI: Diseases of the digestive 
system; XII: Diseases of the skin and subcutaneous tissue; XIII: Diseases of the musculoskeletal system and connective tissue; XIV: Diseases of the 
genitourinary system; XV: Pregnancy, childbirth and the puerperium; XVI: Certain conditions originating in the perinatal period; XVII: Congenital 
malformations, deformations and chromosomal abnormalities; XVIII: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere 
classified; XIX: Injury, poisoning and certain other consequences of external causes.
§ Generalised negative binomial regression model; overdispersion a linear combination of yearBMC Public Health 2007, 7:263 http://www.biomedcentral.com/1471-2458/7/263
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model, estimates of the magnitude of winter:non-winter
mortality from diseases of the circulatory system were
around 40% higher in those aged sixty plus than in those
aged under 30 at the time of death. There was no evidence
to suggest that winter:non-winter circulatory disease
MRRs differed by gender, prioritised ethnicity, NZDep or
RHA.
Discussion
Winter mortality rates in NZ from 1980 to 2000 were 18%
higher than expected from non-winter rates; this is 2%
higher than the mean for 14 European countries [8]. NZ
appears to have similar EWM to the UK with New Zea-
landers more vulnerable to EWM than Scandinavians. We
could not find recent estimates of EWM for other South-
ern Hemisphere countries, although analysis of 1976–
1984 mortality data indicated NZ had more extreme sea-
sonal mortality than Australia and 11 other countries in
the Southern Hemisphere [4,22].
Of the factors thought to indicate vulnerability to winter
death, age was the only clear predictor. Patterns of EWM
by age group followed similar trends to mortality rates
with the young and the elderly particularly vulnerable. In
the older age groups the seasonal increase rose steeply
with age. EWM from respiratory disease was particularly
striking in under-five year olds.
Females may be more vulnerable than males to winter
mortality. After adjusting for all major covariates the win-
ter:non-winter MRR for females was 9% higher than for
males. There was no evidence to suggest that patterns of
EWM differed by ethnicity.
Although the lack of seasonal variation by region is con-
sistent with a number of studies, use of 4 RHAs is a rela-
tively insensitive way of assessing the impact of geography
on seasonal mortality, with climate within regions varying
considerably [4,6]. It would be interesting to compare
Table 3: Rates of mortality from diseases of the respiratory system in winter and non-winter months, ratio of rates and relative change 
in winter:non-winter ratios for potential modifying factors; 1996–2000
p-value




Winter:non-winter ratio relative 
to baseline category§ (95% CI)‡
Winter Non-winter
All 9.4 (5762) 5.5 (6178)
Age (years):
0–4 0.9 (42) 0.4 (35) 2.40 (1.31, 4.41) 1.00
5–14 0.0 (3) 0.0 (4) 1.50 (0.34, 6.58) 0.61 (0.13, 2.96)
15–29 0.1 (16) 0.1 (26) 1.24 (0.62, 2.45) 0.50 (0.22, 1.11)
30–59 1.1 (260) 0.7 (348) 1.49 (1.01, 2.18) 0.61 (0.35, 1.06)
60–79 29.8 (2381) 17.5 (2796) 1.61 (1.31, 1.97) 0.67 (0.40, 1.11)
80+ 180.2 (3060) 103.6 (3509) 1.66 (1.40, 1.97) 0.67 (0.40, 1.13)  p = .56
Gender:
Male 9.4 (2930) 5.9 (3501) 1.64 (1.40, 1.92) 1.00




9.0 (5328) 5.2 (6159) 1.68 (1.39, 2.02) 1.00
Maori 15.7 (434) 9.9 (559) 1.58 (1.08, 2.33) 0.90 (0.72, 1.12)  p = .35
NZDep96:
1–3 7.5 (1233) 4.6 (1504) 1.49 (1.10, 2.03) 1.00
4–6 9.0 (1662) 5.3 (1948) 1.64 (1.23, 2.20) 1.13 (0.93, 1.37)
7–10 10.9 (2867) 6.2 (3266) 1.80 (1.38, 2.35) 1.12 (0.93, 1.36)  p = .40
RHA:
North 8.5 (1790) 4.8 (2012) 1.91 (1.37, 2.64) 1.00
Midland 9.6 (1165) 5.6 (1369) 1.52 (1.08, 2.14) 0.87 (0.70, 1.08)
Central 9.5 (1416) 5.8 (1728) 1.49 (1.06, 2.10) 0.95 (0.77, 1.17)
South 10.6 (1391) 6.2 (1609) 1.71 (1.21, 2.42) 0.95 (0.77, 1.17)  p = .67
* No of deaths in winter correspond to a 4 month period; non-winter, an 8 month period
‡ Generalised negative binomial regression model; overdispersion a linear combination of age group and 
ethnicity
§ Adjusted for all other covariates including covariate by winter interaction terms
† Mortality rates have been age-standardised to account for different population structures of Maori and 
Non-MaoriBMC Public Health 2007, 7:263 http://www.biomedcentral.com/1471-2458/7/263
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EWM between smaller regions and to explore whether
urban-rural differences exist.
Studies of variation of seasonal mortality by socioeco-
nomic status continue to provide conflicting results.
Using a small-area level measure of deprivation this
research found no evidence suggesting that people from
more deprived areas were particularly vulnerable to EWM.
One assumption made when calculating the NZDep
decile associated with a mortality event is that the individ-
ual's last known usual address is applicable. Future
research using individual-level socioeconomic variables
would provide interesting comparisons.
Mortality from respiratory disease was strongly influenced
by season, with winter estimates 66% higher than
expected from non-winter rates. Although the winter:non-
winter MRR for circulatory disease was lower at 24%, mor-
tality from this category had the largest absolute fluctua-
tions between seasons as mortality from circulatory
diseases comprised 40% of total mortality compared to
10% from respiratory disease. Although certain infectious
and parasitic diseases had a strong seasonal pattern, this
grouping contributes only 0.5% of total mortality in NZ.
Analysis using ICD chapters has many limitations as these
categories are broad and not based strictly on aetiology.
For example, a previous analysis of NZ deaths with an
infectious disease cause found that only 10% of those
recorded from 1988–2000 were coded to the ICD-9 infec-
tious disease chapter [23].
Because numerator data were obtained from a difference
source (NZHIS) than population denominators (SNZ),
there are potential errors with calculating rates of mortal-
ity between years and population subgroups. However,
comparisons between winter rates and non-winter rates
should be relatively robust.
The lack of evidence to confirm the role of factors thought
to indicate vulnerability to winter death may have been
Table 4: Rates of mortality from diseases of the circulatory system in winter and non-winter months, ratio of rates and relative change 
in winter:non-winter ratios for potential modifying factors; 1996–2000
 p-value




Winter:non-winter ratio relative 
to baseline category§ (95% CI)‡
Winter Non-winter
All 33.7 (20664) 27.4 (33576) 1.24 (1.13, 1.36)
Age (years):
0–4 0.1 (3) 0.2 (18) 0.33 (.09, 1.22) 1.00†
5–14 0.1 (6) 0.0 (8) 1.50 (0.52, 4.31)
15–29 0.4 (50) 0.4 (112) 0.89 (0.62, 1.27)
30–59 6.8 (1678) 6.2 (3065) 1.05 (0.76, 1.46) 1.30 (0.90, 1.90)
60–79 100.7 (8057) 83.1 (13264) 1.16 (0.95, 1.40) 1.40 (1.00, 1.96)
80+ 640.2 (10870) 505.1 (17109) 1.25 (1.13, 1.37) 1.44 (0.99, 2.08)  p = .22
Gender:
Male 33.8 (10148) 28.0 (16773) 1.28 (1.13, 1.46) 1.00
Female 33.6 (10516) 26.9 (16803) 1.21 (1.06, 1.37) 1.06 (0.94, 1.19) p = .33
Ethnicity^:
Non-Maori 32.3 (19071) 26.2 (30797) 1.27 (1.15, 1.40) 1.00
Maori 55.8 (1593) 46.7 (2779) 1.18 (0.96, 1.44) 0.93 (0.81, 1.07)  p = .32
NZDep96:
1–3 28.7 (4742) 23.5 (7733) 1.20 (1.01, 1.42) 1.00
4–6 34.2 (6325) 27.9 (10292) 1.23 (1.05, 1.45) 1.07 (0.92, 1.24)
7–10 36.4 (9597) 29.6 (15551) 1.28 (1.10, 1.49) 1.04 (0.90, 1.20)  p = .67
RHA:
North 29.1 (6132) 23.7 (9997) 1.24 (1.03, 1.49) 1.00
Midland 34.4 (4200) 27.7 (6754) 1.34 (1.11, 1.62) 0.97 (0.83, 1.15)
Central 35.7 (5338) 28.7 (8563) 1.17 (0.97, 1.42) 1.00 (0.85, 1.18)
South 38.2 (4994) 31.7 (8262) 1.21 (1.00, 1.48) 0.96 (0.81, 1.13)  p = .93
* No of deaths in winter correspond to a 4 month period; non-winter, an 8 month period
‡ Generalised negative binomial regression model; overdispersion a linear combination of age group and 
ethnicity
§ Adjusted for all other covariates including covariate by winter interaction terms
† Because of small cell counts, age group 0–29 years was used as the baseline category
^ Mortality rates have been age-standardised to account for different population structures of Maori and Non-
MaoriBMC Public Health 2007, 7:263 http://www.biomedcentral.com/1471-2458/7/263
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due to limitations in the measurement of factors such as
ethnicity and deprivation at the area level. Statistical
power may also have been an issue with some of the inter-
action terms that we examined for evidence of differential
effects on EWM, but the 137,583 deaths used in the
detailed 1996–2000 analysis would generally not be con-
sidered a small dataset.
A major limitation of the modelling approach taken is the
implied sudden change in mortality rate at the start and
end of winter. Use of a continuous method to model the
pattern of seasonal change would offer a more realistic
approach. Fourier analysis could be used to fit a sinusoi-
dal wave to monthly mortality data and from this model
estimates of absolute and relative differences between
peak mortality and mortality at the nadir could be
obtained.
Exploring the role that meteorological variables (e.g. tem-
perature, humidity) and other seasonal exposures (e.g.
influenza, air pollution) play in EWM was beyond the
scope of this paper. Further research should explore
whether more tailored conclusions could be obtained if
the specific pathways driving EWM were identified. For
example, if annual peaks in winter mortality were associ-
ated with particularly cold indoor temperatures then it
would be sensible to place greater emphasis on improved
home heating and insulation whereas if winter peaks were
associated with influenza epidemics then greater empha-
sis might be placed on more comprehensive influenza
vaccination programme [24]. Future research could also
investigate the effects of other potentially modifiable sea-
sonal factors such as indoor air pollution, household
crowding, and vitamin D deficiency.
Conclusion
EWM in NZ is substantial and at the upper end of the
range observed internationally. Interventions to reduce
EWM are important, but the surprising lack of variation in
EWM by ethnicity, region and deprivation, provides little
guidance for how such mortality can be reduced. More tar-
geted research is needed to explore a number of other pos-
sible factors that could be contributing to EWM, including
the role of climate, influenza, behaviour, crowding in
winter, levels of home heating & thermal performance of
houses.
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